These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 30536320)

  • 1. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-106a promotes breast cancer progression by regulating DAX-1.
    Liu C; Song YH; Mao Y; Wang HB; Nie G
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1574-1583. PubMed ID: 30840280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
    Wang C; Xie XX; Li WJ; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
    Yu XY; Tian JR; Yang D; Tan HR
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
    Shi YF; Lu H; Wang HB
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
    Ma JB; Hu SL; Zang RK; Su Y; Liang YC; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381.
    Gao YT; Zhou YC
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6588-6595. PubMed ID: 31378900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
    Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer.
    Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K
    Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p.
    Cui HX; Zhang MY; Liu K; Liu J; Zhang ZL; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6838-6844. PubMed ID: 30402848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
    Zhong X; Long Z; Wu S; Xiao M; Hu W
    J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA-100219 promotes breast cancer progression by binding to microRNA-485-3p.
    Yao Y; Fang ZZXHSLCNH
    J BUON; 2019; 24(2):501-508. PubMed ID: 31127997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-566 protects the malignant progression of breast cancer by negatively regulating WNT6.
    Zhao MC; Zhang MM; Li T; Tao ZH; Du YQ; Wang LP; Zhang J; Wang BY; Hu XC
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6185-6194. PubMed ID: 32572884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
    Ye J; Jiao Y
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.